AAAAAA

   
Results: 1-25 | 26-28
Results: 1-25/28
COMPARISON OF NEUTRALIZING AND HEMAGGLUTINATION-INHIBITING ANTIBODY-RESPONSES TO INFLUENZA-A VIRUS VACCINATION OF HUMAN IMMUNODEFICIENCY VIRUS-INFECTED INDIVIDUALS
Authors: BENNE CA KROON FP HARMSEN M TAVARES L KRAAIJEVELD CA DEJONG JC
Citation: Ca. Benne et al., COMPARISON OF NEUTRALIZING AND HEMAGGLUTINATION-INHIBITING ANTIBODY-RESPONSES TO INFLUENZA-A VIRUS VACCINATION OF HUMAN IMMUNODEFICIENCY VIRUS-INFECTED INDIVIDUALS, Clinical and diagnostic laboratory immunology, 5(1), 1998, pp. 114-117
REDUCED TOXOPLASMASTATIC ACTIVITY OF MONOCYTES FROM AIDS PATIENTS - AROLE FOR GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR
Authors: DELEMARRE FGA STEVENHAGEN A KROON FP VANFURTH R
Citation: Fga. Delemarre et al., REDUCED TOXOPLASMASTATIC ACTIVITY OF MONOCYTES FROM AIDS PATIENTS - AROLE FOR GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR, Scandinavian journal of immunology, 47(2), 1998, pp. 163-166
RESTORED HUMORAL IMMUNE-RESPONSE TO INFLUENZA VACCINATION IN HIV-INFECTED ADULTS TREATED WITH HIGHLY-ACTIVE ANTIRETROVIRAL THERAPY
Authors: KROON FP RIMMELZWAAN GF ROOS MTL OSTERHAUS AME HAMANN D MIEDEMA F VANDISSEL JT
Citation: Fp. Kroon et al., RESTORED HUMORAL IMMUNE-RESPONSE TO INFLUENZA VACCINATION IN HIV-INFECTED ADULTS TREATED WITH HIGHLY-ACTIVE ANTIRETROVIRAL THERAPY, AIDS, 12(17), 1998, pp. 217-223
PHARMACOKINETIC INTERACTION BETWEEN THE PROTON PUMP INHIBITOR OMEPRAZOLE AND THE HIV PROTEASE INHIBITOR INDINAVIR
Authors: BURGER DM HUGEN PWH KROON FP GROENEVELD P BRINKMAN K FOUDRAINE NA SPRENGER H KOOPMANS PP HEKSTER YA
Citation: Dm. Burger et al., PHARMACOKINETIC INTERACTION BETWEEN THE PROTON PUMP INHIBITOR OMEPRAZOLE AND THE HIV PROTEASE INHIBITOR INDINAVIR, AIDS, 12(15), 1998, pp. 2080-2082
SEVERE MYCOBACTERIAL AND SALMONELLA INFECTIONS IN INTERLEUKIN-12 RECEPTOR-DEFICIENT PATIENTS
Authors: DEJONG R ALTARE F HAAGEN IA ELFERINK DG DEBOER T VRIESMAN PJCV KABEL PJ DRAAISMA JMT VANDISSEL JT KROON FP CASANOVA JL OTTENHOFF THM
Citation: R. Dejong et al., SEVERE MYCOBACTERIAL AND SALMONELLA INFECTIONS IN INTERLEUKIN-12 RECEPTOR-DEFICIENT PATIENTS, Science, 280(5368), 1998, pp. 1435-1438
ANTIBODY-RESPONSE TO HAEMOPHILUS-INFLUENZAE TYPE-B VACCINE IN RELATION TO THE NUMBER OF CD4(-LYMPHOCYTES IN ADULTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS() T)
Authors: KROON FP VANDISSEL JT RIJKERS GT LABADIE J VANFURTH R
Citation: Fp. Kroon et al., ANTIBODY-RESPONSE TO HAEMOPHILUS-INFLUENZAE TYPE-B VACCINE IN RELATION TO THE NUMBER OF CD4(-LYMPHOCYTES IN ADULTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS() T), Clinical infectious diseases, 25(3), 1997, pp. 600-606
ABSENCE OF EPSTEIN-BARR-VIRUS (EBV) IN A GASTROINTESTINAL STROMAL CELL TUMOR (GIST) IN AN ADULT HUMAN IMMUNODEFICIENCY VIRUS-SEROPOSITIVE PATIENT WITH PAST EBV INFECTION
Authors: KUBBEN FJGM KROON FP HOGENDOORN PCW SHAW PC VEENENDAAL RA DEROOS A LAMERS CBHM
Citation: Fjgm. Kubben et al., ABSENCE OF EPSTEIN-BARR-VIRUS (EBV) IN A GASTROINTESTINAL STROMAL CELL TUMOR (GIST) IN AN ADULT HUMAN IMMUNODEFICIENCY VIRUS-SEROPOSITIVE PATIENT WITH PAST EBV INFECTION, European journal of gastroenterology & hepatology, 9(7), 1997, pp. 721-724
LIPOSOMAL AMPHOTERICIN-B (AMBISOME) COMPARED WITH AMPHOTERICIN-B BOTHFOLLOWED BY ORAL FLUCONAZOLE IN THE TREATMENT OF AIDS-ASSOCIATED CRYPTOCOCCAL MENINGITIS
Authors: LEENDERS ACAP REISS P PORTEGIES P CLEZY K HOP WCJ HOY J BORLEFFS JCC ALLWORTH T KAUFFMANN RH JONES P KROON FP VERBRUGH HA DEMARIE S
Citation: Acap. Leenders et al., LIPOSOMAL AMPHOTERICIN-B (AMBISOME) COMPARED WITH AMPHOTERICIN-B BOTHFOLLOWED BY ORAL FLUCONAZOLE IN THE TREATMENT OF AIDS-ASSOCIATED CRYPTOCOCCAL MENINGITIS, AIDS, 11(12), 1997, pp. 1463-1471
PREVALENCE OF PARVOVIRUS B19 INFECTION IN PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS
Authors: VANELSACKERNIELE AMW KROON FP VANDERENDE ME SALIMANS MMM SPAAN WJM KROES ACM
Citation: Amw. Vanelsackerniele et al., PREVALENCE OF PARVOVIRUS B19 INFECTION IN PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS, Clinical infectious diseases, 23(6), 1996, pp. 1255-1260
REJECTION TREATMENT AND CYTOMEGALOVIRUS-INFECTION AS RISK-FACTORS FORPNEUMOCYSTIS-CARINII PNEUMONIA IN RENAL-TRANSPLANT RECIPIENTS
Authors: AREND SM WESTENDORP RGJ KROON FP VANTWOUT JW VANDENBROUCKE JP VANES LA VANDERWOUDE FJ
Citation: Sm. Arend et al., REJECTION TREATMENT AND CYTOMEGALOVIRUS-INFECTION AS RISK-FACTORS FORPNEUMOCYSTIS-CARINII PNEUMONIA IN RENAL-TRANSPLANT RECIPIENTS, Clinical infectious diseases, 22(6), 1996, pp. 920-925
UVEITIS DURING TREATMENT OF DISSEMINATED MYCOBACTERIUM-AVIUM-INTRACELLULARE COMPLEX INFECTION WITH THE COMBINATION OF RIFABUTIN, CLARITHROMYCIN AND ETHAMBUTOL
Authors: LOWE SH KROON FP BOLLEMEYER JG STRICKER BHC VANTWOUT JW
Citation: Sh. Lowe et al., UVEITIS DURING TREATMENT OF DISSEMINATED MYCOBACTERIUM-AVIUM-INTRACELLULARE COMPLEX INFECTION WITH THE COMBINATION OF RIFABUTIN, CLARITHROMYCIN AND ETHAMBUTOL, Netherlands journal of medicine, 48(6), 1996, pp. 211-215
INCREASED PRODUCTION OF NITRIC-OXIDE CORRELATES WITH VIRAL LOAD AND ACTIVATION OF MONONUCLEAR PHAGOCYTES IN HIV-INFECTED PATIENTS
Authors: GROENEVELD PHP KROON FP NIBBERING PH BRUISTEN SM VANSWIETEN P VANFURTH R
Citation: Php. Groeneveld et al., INCREASED PRODUCTION OF NITRIC-OXIDE CORRELATES WITH VIRAL LOAD AND ACTIVATION OF MONONUCLEAR PHAGOCYTES IN HIV-INFECTED PATIENTS, Scandinavian journal of infectious diseases, 28(4), 1996, pp. 341-345
THE EFFECTS OF IMMUNIZATION IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
Authors: KROON FP VANFURTH R BRUISTEN SM
Citation: Fp. Kroon et al., THE EFFECTS OF IMMUNIZATION IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION, The New England journal of medicine, 335(11), 1996, pp. 817-818
ANTIBODY-RESPONSE TO DIPHTHERIA, TETANUS, AND POLIOMYELITIS VACCINES IN RELATION TO THE NUMBER OF CD4(-LYMPHOCYTES IN ADULTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS() T)
Authors: KROON FP VANDISSEL JT LABADIE J VANLOON AM VANFURTH R
Citation: Fp. Kroon et al., ANTIBODY-RESPONSE TO DIPHTHERIA, TETANUS, AND POLIOMYELITIS VACCINES IN RELATION TO THE NUMBER OF CD4(-LYMPHOCYTES IN ADULTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS() T), Clinical infectious diseases, 21(5), 1995, pp. 1197-1203
ABORTIVE AND SUBCLINICAL POLIOMYELITIS IN A FAMILY DURING THE 1992 EPIDEMIC IN THE NETHERLANDS
Authors: KROON FP WEILAND HT VANLOON AM VANFURTH R
Citation: Fp. Kroon et al., ABORTIVE AND SUBCLINICAL POLIOMYELITIS IN A FAMILY DURING THE 1992 EPIDEMIC IN THE NETHERLANDS, Clinical infectious diseases, 20(2), 1995, pp. 454-456
REJECTION TREATMENT AND RISK OF PNEUMOCYSTIS-CARINII PNEUMONIA AFTER RENAL-TRANSPLANT
Authors: AREND SM WESTENDORP RGJ VANTWOUT JW VANDERWOUDE FJ KROON FP VANES LA VANDENBROUCKE JP
Citation: Sm. Arend et al., REJECTION TREATMENT AND RISK OF PNEUMOCYSTIS-CARINII PNEUMONIA AFTER RENAL-TRANSPLANT, Journal of the American Society of Nephrology, 6(3), 1995, pp. 1070-1070
TREATMENT OF POOR-PROGNOSIS EPIDEMIC KAPOSIS-SARCOMA WITH DOXORUBICIN, BLEOMYCIN, VINDESINE AND RECOMBINANT HUMAN GRANULOCYTE-MONOCYTE COLONY-STIMULATING FACTOR (RH GM-CSF)
Authors: BAKKER PJM DANNER SA TENNAPEL CHH KROON FP SPRENGER HG VANLEUSEN R MEENHORST PL MUUSERS A VEENHOF CHN
Citation: Pjm. Bakker et al., TREATMENT OF POOR-PROGNOSIS EPIDEMIC KAPOSIS-SARCOMA WITH DOXORUBICIN, BLEOMYCIN, VINDESINE AND RECOMBINANT HUMAN GRANULOCYTE-MONOCYTE COLONY-STIMULATING FACTOR (RH GM-CSF), European journal of cancer, 31A(2), 1995, pp. 188-192
LIMITED SAMPLING MODELS FOR THE ANTIRETROVIRAL AGENT DIDANOSINE
Authors: BURGER DM MEENHORST PL TENNAPEL CHH MULDER JW HENRICHS JH FRISSEN PHJ KROON FP KOKS CHW BULT A BEIJNEN JH
Citation: Dm. Burger et al., LIMITED SAMPLING MODELS FOR THE ANTIRETROVIRAL AGENT DIDANOSINE, European journal of pharmaceutical sciences, 3(1), 1995, pp. 7-13
ZIDOVUDINE PLUS INTERFERON-ALPHA VERSUS ZIDOVUDINE ALONE IN HIV-INFECTED SYMPTOMATIC OR ASYMPTOMATIC PERSONS WITH CD4-THAN-150X10(6)( CELL COUNTS GREATER)I - RESULTS OF THE ZIDON TRIAL/
Authors: FERNANDEZCRUZ E LANG JM FRISSEN J FURNER V CHATEAUVERT M BOUCHER CAB DOWD P STEVENS J GOLD J MICHELMORE H BENSON E SPELMAN E HOY J WRIGHT E FRENCH M HUDSON J MALLAL S BODSWORTH N STINGL G MAYERHOFER S KRONAWETTER M TSOUKAS C SZABO T KATLAMA C GUERMONPREZ G RAFFI F BILLAUD E MILPIED B BOURGEOT V FLEISHMANN M BARRIER JH DELZANT G WINTER C MEHARZI J TREPO C COTTE L ROUGIER P HASSAIRI N CHOUTET P BESNIER JM LAFEUILLADE A RASOKAT H GROSS G MAUSCH HE STRATIGOS J POLYDOROV D STAVRIANEAS N KIOSSES V MANDALAKI T KARAFOULIDOU A KARABINIS A STERGIOU G PLOUMIDES G PITSAS A TASSOPOULOS N KOUTSOUNOPOULOS G HATZAKIS A MORONI M DARMINIO A BINI T CHIODO F COLANGELI V RICCHI E AIUTI F FERRARA R MEZZAROMA I LANGE JMA FRISSEN PHJ SPRENGER HG KROON FP VANDERENDE ME DEMARIE S KOOPMANS PP DOLMANS WMV SCHREIJ GS WEIGEL HM TENNAPEL CHH TENKATE RW MARANON G ZABAY JM COSIN J PENA JM RUBIO R RIBERA E VAZQUEZ JMM LEAL M ANDREU J CARTON JA ASENSI V GOMEZTRUJILLO F ORIHUELA F SERRANO C FERRER E MANDAL BK JOHNSON M MCKARTHY K FARMER D TANG A MITCHELL SA BROWN J TOORAWA R YEO J
Citation: E. Fernandezcruz et al., ZIDOVUDINE PLUS INTERFERON-ALPHA VERSUS ZIDOVUDINE ALONE IN HIV-INFECTED SYMPTOMATIC OR ASYMPTOMATIC PERSONS WITH CD4-THAN-150X10(6)( CELL COUNTS GREATER)I - RESULTS OF THE ZIDON TRIAL/, AIDS, 9(9), 1995, pp. 1025-1035
REDUCED TOXOPLASMASTATIC ACTIVITY OF MONOCYTES AND MONOCYTE-DERIVED MACROPHAGES FROM AIDS PATIENTS IS MEDIATED VIA PROSTAGLANDIN E(2)
Authors: DELEMARRE FGA STEVEHAGEN A KROON FP VANEER MY MEENHORST PL VANFURTH R
Citation: Fga. Delemarre et al., REDUCED TOXOPLASMASTATIC ACTIVITY OF MONOCYTES AND MONOCYTE-DERIVED MACROPHAGES FROM AIDS PATIENTS IS MEDIATED VIA PROSTAGLANDIN E(2), AIDS, 9(5), 1995, pp. 441-445
PNEUMOCYSTIS-CARINII PNEUMONIA IN PATIENTS WITHOUT AIDS, 1980 THROUGH1993 - AN ANALYSIS OF 78 CASES
Authors: AREND SM KROON FP VANTWOUT JW
Citation: Sm. Arend et al., PNEUMOCYSTIS-CARINII PNEUMONIA IN PATIENTS WITHOUT AIDS, 1980 THROUGH1993 - AN ANALYSIS OF 78 CASES, Archives of internal medicine, 155(22), 1995, pp. 2436-2441
PHARMACOKINETIC INTERACTION STUDY OF ZIDOVUDINE AND DIDANOSINE
Authors: BURGER DM MEENHORST PL KROON FP MULDER JW KOKS CHW BULT A BEIJNEN JH
Citation: Dm. Burger et al., PHARMACOKINETIC INTERACTION STUDY OF ZIDOVUDINE AND DIDANOSINE, Journal of drug development, 6(4), 1994, pp. 187-194
PREVENTION OF NOSOCOMIAL SPREAD OF MULTIDRUG-RESISTANT TUBERCLE-BACILLI
Authors: VANEER MY KROON FP VANFURTH R
Citation: My. Vaneer et al., PREVENTION OF NOSOCOMIAL SPREAD OF MULTIDRUG-RESISTANT TUBERCLE-BACILLI, Netherlands journal of medicine, 44(6), 1994, pp. 220-226
ANTIBODY-RESPONSE TO INFLUENZA, TETANUS AND PNEUMOCOCCAL VACCINES IN HIV-SEROPOSITIVE INDIVIDUALS IN RELATION TO THE NUMBER OF CD4+ LYMPHOCYTES
Authors: KROON FP VANDISSEL JT DEJONG JC VANFURTH R
Citation: Fp. Kroon et al., ANTIBODY-RESPONSE TO INFLUENZA, TETANUS AND PNEUMOCOCCAL VACCINES IN HIV-SEROPOSITIVE INDIVIDUALS IN RELATION TO THE NUMBER OF CD4+ LYMPHOCYTES, AIDS, 8(4), 1994, pp. 469-476
EFFECT OF IFN-GAMMA ON THE PROLIFERATION OF TOXOPLASMA-GONDII IN MONOCYTES AND MONOCYTE-DERIVED MACROPHAGES FROM AIDS PATIENTS
Authors: DELEMARRE FGA STEVENHAGEN A KROON FP VANEER MY MEENHORST PL VANFURTH R
Citation: Fga. Delemarre et al., EFFECT OF IFN-GAMMA ON THE PROLIFERATION OF TOXOPLASMA-GONDII IN MONOCYTES AND MONOCYTE-DERIVED MACROPHAGES FROM AIDS PATIENTS, Immunology, 83(4), 1994, pp. 646-650
Risultati: 1-25 | 26-28